Introduction of hsa‐miR‐103a and hsa‐miR‐1827 and hsa‐miR‐137 as new regulators of Wnt signaling pathway and their relation to colorectal carcinoma

Abstract

Wnt signaling is hyper-activated in most of human cancers including colorectal carcinoma (CRC). Therefore, the introduction of new regulators for Wnt pathway possesses promising diagnostic and therapeutic applications in cancer medicine. Bioinformatics analysis introduced hsa-miR-103a, hsa-miR-1827, and hsa-miR-137 as potential regulators of Wnt signaling pathway. Here, we intended to examine the effect of these human miRNAs on Wnt signaling pathway components, on the cell cycle progression in CRC originated cell lines and their expression in CRC tissues. RT-qPCR results indicated upregulation of hsa-miR-103a, hsa-miR-1827, and downregulation of hsa-miR-137 in CRC tissues. Overexpression of hsa-miR-103a and hsa-miR-1827 in SW480 cells resulted in elevated Wnt activity, detected by both Top/Flash assay and RT-qPCR analysis. Inhibition of Wnt signaling by using PNU-74654 or IWP-2 small molecules suggested that these miRNAs exerts their effect at the β-catenin degradation complex level. Then, RT-qPCR, dual luciferase assay, and western blotting analysis indicated that APC and APC2 transcripts were targeted by hsa-miR-103a, hsa-miR-1827 while, Wnt3a and β-catenin genes were upregulated. However, hsa-miR-137 downregulated Wnt3a and β-catenin genes. Further, hsa-miR-103a and hsa-miR-1827 overexpression resulted in cell cycle progression and reduced apoptotic rate in SW480 cells, unlike hsa-miR-137 overexpression which resulted in cell cycle suppression, detected by flowcytometry and Anexin analysis. Overall, our data introduced hsa-miR-103a, hsa-miR-1827 as onco-miRNAs and hsa-miR-137 as tumor suppressor which exert their effect through regulation of Wnt signaling pathway in CRC and introduced them as potential target for therapy.

Retracted Article: Exosome-derived PTENP1 suppresses cisplatin resistance of bladder cancer (BC) by suppressing cell proliferation, migration and inducing apoptosis via the miR-103a/PDCD4 axis

“…32 Moreover, miR-103a participated in cell progression in colorectal carcinoma or gastric cancer by regulating Wnt pathway or ATF7. 33,34 Therefore, it is of great clinical signicance to reveal the role of miR-103a in DDPresistant BC cells.…”

MiR‐137 inhibited inflammatory response and apoptosis after spinal cord injury via targeting of MK2

“…MiR‐137 is located at chromosome 1q32.1. While miR‐137 is more usually reported as a tumor suppressor via binding to its different downstream targets in various malignant tumors including melanoma, colorectal carcinomas, non‐small cell lung cancer, and hepatocellular carcinoma . MiR‐137 was also reported as taking part in Alzheimer's disease, Parkinson's disease, schizophrenia and in neural development, and neoplastic transformation .…”

miR-103 Promotes Neurite Outgrowth and Suppresses Cells Apoptosis by Targeting Prostaglandin-Endoperoxide Synthase 2 in Cellular Models of Alzheimer’s Disease

“…miR-103, belonging to miR-103/107 family, has been greatly studied in various cancers but not in neurologic diseases (Fasihi et al, 2017 ; Kfir-Erenfeld et al, 2017 ; Yang et al, 2017 ; Zheng et al, 2017 ). A previous study illuminates that miR-103 improves cancer progress via regulating Wnt signaling pathway in colorectal carcinoma (Fasihi et al, 2017 ). Another study reveals that miR-103 increases cells proliferation and metastasis through targeting Krüppel-like Factor-4 (KLF4) in gastric cancer (Zheng et al, 2017 ).…”